XML 92 R78.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SEGMENT INFORMATION - Schedule of Reportable Segments (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2024
USD ($)
segment
Mar. 31, 2023
USD ($)
Segment Reporting [Abstract]    
Number of reportable segments | segment 3  
Financial information regarding the Company's reportable segments    
Net Sales $ 915,448 $ 860,067
Acquisition-related costs 0 (255)
Restructuring Initiatives (3,480) (11,524)
Net unrealized investment gain 592 188
Depreciation and amortization (64,349) (59,259)
Interest Expense (10,175) (10,228)
Interest Income 2,898 672
Income before Income Taxes 104,318 73,269
Optimization initiative    
Financial information regarding the Company's reportable segments    
Restructuring Initiatives (3,497) (11,540)
Prior year initiatives    
Financial information regarding the Company's reportable segments    
Restructuring Initiatives 17 16
Aptar Pharma    
Financial information regarding the Company's reportable segments    
Net Sales 407,293 356,046
Aptar Beauty    
Financial information regarding the Company's reportable segments    
Net Sales 327,320 326,389
Aptar Closures    
Financial information regarding the Company's reportable segments    
Net Sales 180,835 177,632
Operating segment    
Financial information regarding the Company's reportable segments    
Net Sales 925,067 869,888
Operating segment | Aptar Pharma    
Financial information regarding the Company's reportable segments    
Net Sales 407,490 356,111
Adjusted EBITDA 132,178 109,298
Restructuring Initiatives (24) (1,131)
Operating segment | Aptar Beauty    
Financial information regarding the Company's reportable segments    
Net Sales 334,880 333,338
Adjusted EBITDA 41,134 37,205
Restructuring Initiatives (2,710) (9,291)
Operating segment | Aptar Closures    
Financial information regarding the Company's reportable segments    
Net Sales 182,697 180,439
Adjusted EBITDA 27,161 26,008
Restructuring Initiatives (760) (522)
Intersegment    
Financial information regarding the Company's reportable segments    
Net Sales 9,619 9,821
Intersegment | Aptar Pharma    
Financial information regarding the Company's reportable segments    
Net Sales 197 65
Intersegment | Aptar Beauty    
Financial information regarding the Company's reportable segments    
Net Sales 7,560 6,949
Intersegment | Aptar Closures    
Financial information regarding the Company's reportable segments    
Net Sales 1,862 2,807
Corporate & Other, unallocated    
Financial information regarding the Company's reportable segments    
Adjusted EBITDA (21,641) (18,836)
Restructuring Initiatives $ 14 $ (580)